Market Overview

ADMA Biologics (NASDAQ: ADMA)

2.38 -0.03 (-1.24%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/07/20OppenheimerMaintainsOutperform7.0
3/16/20H.C. WainwrightMaintainsBuy12.0
6/04/19JefferiesInitiates Coverage OnBuy8.0
4/02/19OppenheimerMaintainsOutperform16.0
2/07/19H.C. WainwrightAssumesBuy10.0
10/30/18H.C. WainwrightInitiates Coverage OnBuy17.0
10/12/18Raymond JamesMaintainsOutperform10.0
7/30/18Chardan CapitalInitiates Coverage OnBuy10.0
7/27/18Maxim GroupMaintainsBuy12.0
7/26/18Maxim GroupMaintainsBuy12.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter